Grufity logo
Grufity logo
EYES

EYES - Second Sight Medical Products Inc Stock Price, Fair Value and News

$25.80+0.12 (+0.47%)
Market Closed as of 15 Jun 2026, 04:00 pm ET

Price Targets

Target 1Y

Login to View

Target 6M

Login to View

EYES Stock Valuation Analysis

Valuation

Login to View

Max Portfolio %

Login to View

EYES Price Action

Last 7 days

-2.4%

Last 30 days

2.5%

EYES RSI Chart

EYES Stock Valuation Analysis

Valuation

Login to View

Max Portfolio %

Login to View

EYES Valuation

Market Cap

2.2B

Price/Earnings (Trailing)

-80.63

Price/Sales (Trailing)

4.9K

EV/EBITDA

-82.74

Price/Free Cashflow

-82.34

EYES Price/Sales (Trailing)

The Good, Bad and Ugly

Growth

Profitability

Size

Dilution Risk

Balance Sheet

Momentum

Funds Popularity

Insider Trading

Price Targets

Target 1Y

Login to View

Target 6M

Login to View

EYES Fundamentals

EYES Revenue

Revenue (TTM)

475.0K

EYES Earnings

Earnings (TTM)

-27.1M

Earnings Growth (Yr)

-7.58%

Earnings Growth (Qtr)

-2.22%

EYES Profitability

Operating Margin

-877.98%

EBT Margin

-5601.89%

Return on Equity

-141.93%

Return on Assets

-63.96%

Free Cashflow Yield

-1.21%

EYES Investor Care

Shares Dilution (1Y)

45.56%

Diluted EPS (TTM)

-0.4

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs(opens in new tab)
Net sales
YearQ1Q2Q3Q4
2022512.5K--475.0K
20212.2M1.7M1.1M550.0K
2020---2.8M
20197.0M6.4M4.6M3.4M
20187.9M7.6M8.2M6.9M
20173.9M5.1M5.6M8.0M
20168.3M6.7M5.6M4.0M
20154.4M6.5M8.1M8.9M
20142.0M2.5M2.9M3.4M
2013---1.6M
Get all data in R, Python etc through our Historical Stock Data APIs(opens in new tab)

About Second Sight Medical Products Inc

EYES
0
 WEBSITEsecondsight.com

Second Sight Medical Products Inc Frequently Asked Questions

EYES is the stock ticker symbol of Second Sight Medical Products Inc. Every public company that trades on a stock exchange gets a ticker symbol.

As of Mon Jun 15 2026, market cap of Second Sight Medical Products Inc is 2.18 Billion. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.

As of Mon Jun 15 2026, EYES's PE ratio (Price to Earnings) is -80.63 and Price to Sales (PS) ratio is 4.86 Thousand. The price to earnings and price to sales ratio are two most important valuation metrics for any company. PE ratio tell us the number of years of earnings investors are ready to pay for owning the company. Historically, S&P500 price to earnings ratio has fallen below 12 during periods of gloom and gone past 30 during periods of euphoria. EYES PE ratio will change depending on the future growth rate expectations of investors.

In the past 10 years, Second Sight Medical Products Inc has provided -0.015 (multiply by 100 for percentage) rate of return.